Cardiomo Care

Cardiomo provides a revolutionary 'continuous' cardiac monitoring wearable that tracks vital signs (ECG, heart rate, breath rate, skin temperature) using new generation bio sensors and AI to detect cardiac events with 99.63% accuracy, and provide early life-saving alerts.

Paying customers (250)
Pilots - Luz Saude (Portugal), ArcelorMittal (Kazakhstan), Heart Center, Dobrobut (Ukraine) 2018
Partnership - Telefonica (Germany) 2018
Commercial launch - Kyivstar (Ukraine) 2019
Mass production of devices
Android and iOS apps are officially out
Professional dashboard for healthcare practitioners is created
Professional dashboard for enterprise is created
Report for doctors is created
Team completed
Investment $750,000

Our market approach is mix of B2B and B2B2C, directly to the medical providers, and to end-users through channels such as Insurers, Telcos and Pharmacies.

As the global CVD death toll is 17 million people annually and keeps growing, early detection could save millions of lives.
The major problem with CVD detection is that 73% of people with cardiovascular diseases fail to notice or neglect early symptoms of their disease, hence turning to doctors too late or not at all.

Our product is a waterproof wearable patch, which is suitable for long periods of wearing with a battery lasting for 10 days.  The data is channelled via a proprietary mobile app to a secure cloud and is analyzed using AI engine trained on existing and ever-growing data sets to enable early warning for heart diseases.

These are our competitors: VitalConnect https://vitalconnect.com
iRhythm http://irhythmtech.com
AliveCor https://www.alivecor.com

We are uniquely positioned to enable preventive care, continuous cardiac monitoring. Most solutions available today are offline or short period or complicated or if on-line can measure 20% of vitals and not medical grade.
Advantages:
1. Smart decision for doctors - event annotations for faster diagnosis
2. Preventive care for patient - live cardiac monitoring over longer periods
3. Event prediction - detect likely medically actionable events before they occur
4. Patch is reusable - single patch can be reused again or by multiple patients
5. Battery life - 10 days rechargeable battery
6. Medical Grade data that is usable by the doctors

Revenue streams
Healthcare Providers (B2B – hospitals, caregivers)
Health Insurers (B2B – private, employees)
Sport & Geriatric (B2B2C – specialized retail chains)

Uses: FDA 501K and CE Mark approval, Serial Manufacturing, Growing the Team, and Market Entry.

Starta Accelerator, 2016 (USA, New York)
Vienna Business Agency, 2017, (Austria)
Protechting, 2018 (Portugal)
Plug and Play Health Program, 2018 (USA, Sunnyvale)

• Wearable Technologies Show, 2017 (London, the UK) Highly Commended in Digital Health Technology Nomination
• 7 Top Health Startups at Pioneers Festival, 2017 Austria
• 50 Top Startups at Cube Fair Tech, 2017 Germany
• 5 Top Startups in Preventive Medicine & Digital Patient Pathways at Health. Pioneers, 2017, Netherlands
• Sabit IT Starups alumna, 2017
• Winner of TechCrunch Meet up 2017, Poland
• finalist of Falling Walls, 2017 (Ukraine)
• Grant from BNP Paribas, 2017
• Winner of Engineering Startup Competition, 2017, grant from Noosphere Ventures
• Winner of Techstars pitch competition at CES 2018 (USA)
• Finalist of The American Heart Association HEALTH TECH COMPETITION, 2018, Chicago (USA)
• Woman of the Year 2018 in Ukraine Business Startup Nomination
• grant from CRDF Global - winner of CRDF Global Bootcamp Ukraine 2018
• winner of 2018 Global Startup Competition by Brinc, (San Francisco, USA)
• Plug and Play Health Program alumna, 2018, (USA)
• 40 under 40 Emerging Leaders in Biotech, (USA)
• The most powerful woman of Ukraine 2018 (28 place)
• Shortlisted for the Top 10 CEO in Healthcare at the Smart Health Conference , 2018 (Las Vegas, USA)

registered trade mark (USA, Europe, China, Ukraine)
provisional patents (USA)

Link>>>